A new study from the Johns Hopkins Arthritis Center reveals that cigarette smoking is not linked to the development of antibodies to PAD4 in patients with severe rheumatoid arthritis.
GRASPing the Factors associated with Severe Scleroderma in African Americans
We report results from analysis of clinical, laboratory and socio-demographic data provided by the GRASP cohort, which has enhanced our knowledge about factors associated with significant manifestations of scleroderma in African Americans.
Secret Messages : Decoding with Filters
For too long, doctors treating rheumatic diseases have had to base their management on instinct and experience.
The problem is that each physician has a limited experience – which means that many times we basically had to guess at how to treat a specific patient, using trial and error to find out what might work best.
The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Post Treatment Lyme Disease Syndrome
This study shows that well-validated symptom surveys could be used by doctors to identify suggestive symptom patterns that could lead to the diagnosis of PTLDS.
Matters of the heart: a newly discovered type of inflammatory muscle disease with heart involvement
An antibody biomarker was recently discovered that identifies people with chronic skeletal muscle disease and severe heart muscle involvement.
The Value of the Patient’s Perspective in Myositis Research
A survey of more than 600 people with myositis from the US, Korea, and Sweden identified 5 aspects of living with the disease that are most important to patients.
Muscle biopsy findings identify a unique subgroup of patients with severe Scleroderma
A new study found that people with scleroderma who have muscle weakness due to the accumulation of fibrous tissue in their muscles, are at risk for severe disease outcomes including death from heart disease.
Guidelines for Treating Arthritis Caused by New Cancer Therapies
A collaborative effort between Rheumatology and Oncology offers guidance to doctors treating patients for inflammatory arthritis caused by treatment with “immune checkpoint inhibitors”, a type of cancer therapy.
Hiker’s Feet: A new skin finding in patients with dermatomyositis
A study lead by Lisa Christopher-Stine, M.D., M.P.H. identified “Hiker’s Feet” as a new skin finding in some patients with inflammatory muscle disease (myositis).
